Atlas Trials

A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension

Clinical trial NCT02906579 · COMPLETED

Trial details

NCT number
NCT02906579
Sponsor
Cyclerion Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Hypertension
Start date
2016-09-01
Primary completion
2017-03-17
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.